• The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies- Findings from the INITIATOR Study

    Dec 1, 2017, 00:00

  • Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure- A Network Meta-Analysis

    Dec 1, 2017, 00:00

  • Table of Contents

    Dec 1, 2017, 00:00

  • Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer

    Dec 1, 2017, 00:00

  • A (Latent) Class of Their Own- Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises

    Dec 1, 2017, 00:00

  • Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise

    Dec 1, 2017, 00:00

  • Copyright/Subscription

    Dec 1, 2017, 00:00

  • Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer- The OPTIMA Prelim Trial

    Dec 1, 2017, 00:00

  • Scientific Evidence in Health Technology Assessment Reports- An In-Depth Analysis of European Assessments on High-Risk Medical Devices

    Dec 1, 2017, 00:00

  • ISPOR Code of Ethics 2017 (4th Edition)

    Dec 1, 2017, 00:00

  • Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit

    Dec 1, 2017, 00:00

  • Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors

    Dec 1, 2017, 00:00

  • Author Response- Patient Engagement

    Dec 1, 2017, 00:00

  • Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial- An Update with Empirical Trial–Based Cost Data

    Dec 1, 2017, 00:00

  • Development and Validation of the AFImpact- An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life

    Dec 1, 2017, 00:00

  • Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation- A Multicriteria Decision Analysis

    Dec 1, 2017, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Cost-Utility Analysis

    Dec 1, 2017, 00:00

  • Comparing Methods for Estimating Direct Costs of Adverse Drug Events

    Dec 1, 2017, 00:00

  • Next Edition of the ISPOR Code of Ethics- Is It Setting Us up for the Era of Digitized Health Care?

    Dec 1, 2017, 00:00

  • Health Care System

    Dec 1, 2017, 00:00

  • Reviewer Acknowledgement 20/10

    Dec 1, 2017, 00:00

  • The Role of Noncomparative Evidence in Health Technology Assessment Decisions

    Dec 1, 2017, 00:00

  • Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life, Work Productivity And Activity Impairment Associated With Clostridium Difficile Infection In China, Brazil, Europe and The United States

    Oct 1, 2017, 00:00

  • Costs and Benefits of Implementing Non-Invasive Prenatal Testing For Trisomy 21 (T21) Based on Cell Free DNA (CFDNA) Sequencing In Maternal Plasma In France

    Oct 1, 2017, 00:00

  • The Impact Of Human Papillomavirus Vaccine In Taiwan- A Transmission Dynamic Modelling Approach

    Oct 1, 2017, 00:00

  • Patient Insights In Copd Medication Adherence From Pharmacy Data

    Oct 1, 2017, 00:00

  • Analysis of Drug Utilisation Data Sources to Enable Nationwide Value-Based Pricing of Medicines Across Healthcare Systems in Europe

    Oct 1, 2017, 00:00

  • When And Where To Use Furigana? The Application Of Phonetic Notation In Japanese Translations Of Clinical Outcomes Assessments (COAS) For Children

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Afatinib Versus Gefitinib in Egfr-Mutated Population with Advanced Non-Small-Cell Lung Cancer in France

    Oct 1, 2017, 00:00

  • Value and Impact of Incorporating Uncertainty into Opinion Based Research- Study on American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) for Cystic Fibrosis (CF)

    Oct 1, 2017, 00:00

  • Burden of Hospitalizations Related To Spinal Tumors in Fran Evolution Between 2012 and 2014

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Modeling Evaluation Comparing Originator Follitropin Alfa To A Biosimilar For The Treatment of Infertility In Germany, Italy And Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Edoxaban In Patients With Non-Valvular Atrial Fibrillation In Hong Kong

    Oct 1, 2017, 00:00

  • Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary

    Oct 1, 2017, 00:00

  • Antineoplásicos De Maior Impacto Financeiro No Instituto Nacional De Cancer Do Brasil

    Oct 1, 2017, 00:00

  • Real World Evidence in Glaucomatous Diseases- Emr Data is Indispensible For Understanding Patient Journeys and Optimizing Care

    Oct 1, 2017, 00:00

  • Dispute Issues About The Healing And Health Promotion Of Children

    Oct 1, 2017, 00:00

  • The Utilisation Of Biosimilar Infliximab By English Acute Trusts

    Oct 1, 2017, 00:00

  • To Determine The Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA)

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Glioblastoma Multiforme (GBM) Patients Treated at the Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • Economic Burden of Autism and Autism-Related Spectrum Disorders (Asd) In EU5 Countries

    Oct 1, 2017, 00:00

  • Análisis Comparativo De Costos Entre Trastuzumab Para Administración Subcutánea En Comparación Con La Formulación Para Administración Intravenosa Desde La Perspectiva De La Seguridad Social Costarricense

    Oct 1, 2017, 00:00

  • A Retrospective Premier Database Study To Compare Repair of Ventral Hernia With Phasixtm VS Stratticetm In The Inpatient Hospital Surgical Setting

    Oct 1, 2017, 00:00

  • Conceptual Modeling Framework for Global Functioning of Adhd Patients

    Oct 1, 2017, 00:00

  • Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke

    Oct 1, 2017, 00:00

  • Real-World Data Analysis of Cancer Treatment Cost Drivers By Type and Place of Service

    Oct 1, 2017, 00:00

  • Expected Value of Information Analysis to Evaluate the Potential Gains of an RCT Comparing Wound Dressings

    Oct 1, 2017, 00:00

  • Effects of Adherence to Pharmacological Secondary Prevention After Myocardial Infarction on Healthcare Expenditures

    Oct 1, 2017, 00:00

  • Intensity Modulated Radiation Therapy In Malignant Pleural Mesothelioma; A Piolt For Treatment Outcomes And Cost-Effective Expectations

    Oct 1, 2017, 00:00

  • Cost and Effectiveness of the use of Sorafenib in Differentiated Thyroid Cancer

    Oct 1, 2017, 00:00

  • Health Economic Analysis Of Pneumococcal Conjugated Vaccines For Mexico, Under A Technical Parity Scenario

    Oct 1, 2017, 00:00

  • The Presentation Of Patients With Epistaxis Shows A Marked Seasonal Variation In Germany

    Oct 1, 2017, 00:00

  • Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis- A Cross-Country Review of Access Conditions

    Oct 1, 2017, 00:00

  • Characterization And Approximation Of The Direct Costs Of Axial And Peripheral Spondyloarthritis In A Clinical Management Center In Colombia

    Oct 1, 2017, 00:00

  • 90-Day Mortality And Its Predictors In Men With Contralateral Hip Fracture After Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • DATABASE ANALYSIS OF A SUPPORT PROGRAM FOR PEDIATRIC PATIENTS USING SOMATROPIN DUE TO GROWTH HORMONE DEFICIENCY (GHD)

    Oct 1, 2017, 00:00

  • Advanced Monte-Carlo Sampling Schemes for Value of Information Estimation

    Oct 1, 2017, 00:00

  • Impact of Metabolic Surgery on Cost and Long-Term Health Outcome- A Cost-Effectiveness Approach

    Oct 1, 2017, 00:00

  • Comparison of Secukinumab Vs Infliximab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Evolution of The Time-To-Market of Hospital Products In Spain

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia B Patients Using Standard And Extended Half-Life Recombinant Factor IX Products

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Point-Of-Care Test For Renal Function Measurement In Community Pharmacies In The Netherlands To Prevent Antibiotic-Related Hospitalizations

    Oct 1, 2017, 00:00

  • Economic Evaluation Of A Brief Counselling For Smoking Cessation In Dentistry – A Case Study Comparing Two Health Economic Models

    Oct 1, 2017, 00:00

  • Descalonamento Da Terapia Antimicrobiana- Uma Estratégia De Racionalização E Custo-Minimização Em Cenário Privado De Saúde No Ceará

    Oct 1, 2017, 00:00

  • Secondary Care Resource Utilization And Cost Of Care Among Finnish Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Economic Evaluation And Cost-Effectiveness Threshold In Practice Of Decision-Making On Orphan Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • Systematic Review On Economic Impact Of Air Pollution On Health

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden- Analysis Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Impact Of Seasonal Infections On Overcrowding In A Paediatric Department Of A French Hospital In Marseille- A Retrospective Analysis

    Oct 1, 2017, 00:00

  • Modelling The Societal Impact Of Alirocumab In Patients With Severe Hypercholesterolemia Treated With Apheresis In Germany

    Oct 1, 2017, 00:00

  • Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)

    Oct 1, 2017, 00:00

  • Efficacy-Based Budget Impact Analysis of Secukinumab Vs Adalimumab in the Treatment of Ankylosing Spondylitis in Finland

    Oct 1, 2017, 00:00

  • Impact Of Non-Randomised Drop-Out On Treatment Switching Adjustment In The Relapsing-Remitting Multiple Sclerosis Clarity Trial And The Clarity Extension Study

    Oct 1, 2017, 00:00

  • Delaying Second Line Diabetes Treatment Onset In Patients Uncontrolled With Metformin Xr In Saudi Arabia- Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Intermediate Evaluation of Vivoptim- The Mgen (French Insurer) Prevention Program for Cardiovascular Risks

    Oct 1, 2017, 00:00

  • An Innovative Solution to Achieve Cost-effectiveness and A Positive Nice Appraisal? – The Cabazitaxel Case Study

    Oct 1, 2017, 00:00

  • Xelox Versus Folfox No Tratamento Do Câncer Colorretal- Revisão De Estudos Farmacoeconômicos

    Oct 1, 2017, 00:00

  • Mechanisms Of Trade Margin Regulation Of Prescription Drugs- Comparison Of 15 Eu Countries

    Oct 1, 2017, 00:00

  • The Analysis Of New Drug Reimbursement Decision Making In South Korea After The Introduction Of Positive Listing System

    Oct 1, 2017, 00:00

  • Budget Impact Model of Cobimetinib in Combination with Vemurafenib For Previously Untreated Braf V600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

    Oct 1, 2017, 00:00

  • Payers, Politics and Pandemonium- An Insight Into The Future Uk Pricing and Market Access Environment

    Oct 1, 2017, 00:00

  • Public Health And Economic Benefits Of Quadrivalent Influenza Vaccine In Mexico

    Oct 1, 2017, 00:00

  • Identification Of Important Criteria For Drug Reimbursement Decision-Making And Their Relative Importance

    Oct 1, 2017, 00:00

  • Economic Evaluation And Budget Impact Analysis Of Prothrombin Complex Concentrate (Beriplex®) For Treatment And Prophylaxis Of Bleeding In Patients Treated With Oral Anticoagulants Under Perspective Of Health Public Institutions In Mexico

    Oct 1, 2017, 00:00

  • A Retrospective Study On The Antiretroviral Drug Dispensing And Adherence Of The Hungarian HIV Infected Population

    Oct 1, 2017, 00:00

  • Using Observational Data From Registry In Cost-Effectiveness Evaluation of Metastatic Castration Resistant Prostate Cancer In France

    Oct 1, 2017, 00:00

  • Evaluating Endpoints and Changing Trends In Advanced Stages of Cancer Related Clinical Trials

    Oct 1, 2017, 00:00

  • Processes And Requirements For Health Economic Assessment Of Antibiotics For Hta Purposes- Time For A Paradigm Shift?

    Oct 1, 2017, 00:00

  • Publication Timing and Data Utilisation in Cost-Effectiveness Analyses in Non-Small Cell Lung Cancer – A Literature Analysis on Publication Timing

    Oct 1, 2017, 00:00

  • Experiences With Price Competition Of Biosimilar Drugs In Hungary

    Oct 1, 2017, 00:00

  • 10 Years Of Reimbursement Decisions In The Netherlands- An Overview

    Oct 1, 2017, 00:00

  • Time To Clinically Meaningful Worsening In Hepatocellular Carcinoma Patients Treated With Lenvatinib or Sorafenib

    Oct 1, 2017, 00:00

  • Community Pharmacists’ Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Evaltuation of The National Drug Formularium and Electronic Catalog For The Indonesian UHC

    Oct 1, 2017, 00:00

  • An Evidence-Based Approach to Predict Long-Term Patient Outcomes and Key Value Drivers

    Oct 1, 2017, 00:00

  • A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Urban Breast Cancer Screening Programme In China

    Oct 1, 2017, 00:00

  • Efficacy of Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease- Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States

    Oct 1, 2017, 00:00

  • Capturing Patient Perspectives In The Evaluation Of Medical Devices- The Case Of Central Venous Access Devices In Chemotherapy

    Oct 1, 2017, 00:00

  • AVALIAÇÃO ECONÔMICA DE TECNOLOGIAS NA ÁREA DE NUTRIÇÃO- APLICAÇÕES E LIMITAÇÕES PARA O CONTEXTO BRASILEIRO

    Oct 1, 2017, 00:00

  • Could Healthcoin Be A Revolution In Healthcare?

    Oct 1, 2017, 00:00

  • Association Between Monthly Joint Replacement Volume and Patient Outcomes

    Oct 1, 2017, 00:00

  • Early Scientific Advice At Cadth – Options and Recommendations For Future Development

    Oct 1, 2017, 00:00

  • Are PR Approval Of Orphan Drugs (ODS) In Spain?

    Oct 1, 2017, 00:00

  • Evaluating Patients’ Preferences for Dulaglutide Versus Insulin Glargine Profiles in the United Kingdom- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Hospital Costs Associated With Dedicated Vascular Endoprosthesis Versus Prosthetic Bypass In Popliteal Artery Aneurysm Treatment In France

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apremilast for The Treatment of Moderate To Severe Psoriasis In Greece

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Dexmedetomidine Versus Propofol Or Midazolam Sedation In Mechanical Ventilated Icu Patients In Spain

    Oct 1, 2017, 00:00

  • Validity of Change In Recall Period For The Norfolk QOL Patient Reported Outcome (PRO) Measure

    Oct 1, 2017, 00:00

  • Navigating The Road To Reimbursement And Optimizing Uptake For Oncology Agents In The EU5- Payer And Prescriber Perspectives On The Power Of Pivotal Trial Design

    Oct 1, 2017, 00:00

  • Effectiveness and Persistence of The First Tumor Necrosis Factor Inhibitor In Portuguese Psoriatic Arthritis Patients

    Oct 1, 2017, 00:00

  • Healthcare Costs of Ipilimumab in Patients with Advanced Cutaneous Melanoma in Dutch Clinical Practice

    Oct 1, 2017, 00:00

  • Cost-Comparison Between the Etonogestrel Implant and the Medroxyprogesterone Acetate Injectable- Number of Unintended Pregnancies and Financial Impact

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared With Standard Acei Therapies For Heart Failure Patients With Reduced Ejection Fraction In Taiwan

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure With Reduced Ejection Fraction In Korea

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Multi-Gene Panel In The Context Of Reducing Adverse Drug Reactions

    Oct 1, 2017, 00:00

  • An Algorithm To Develop Correlated Multivariate Non-Normal (E.G. Beta, Gamma, Log-Normal) Distributions To Be Used In Probabilistic Sensitivity Analyses (PSAS)

    Oct 1, 2017, 00:00

  • Cost Associated with Ballon-Expandable Valve vs Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • Impact of End-Stage Renal Disease on Health Economic Outcomes of Hyperkalaemia Management In Patients With Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Visual Outcome of Cataract Surgery At Gondar University Hospital Tertiary Eye Care and Training Center, North West Ethiopia

    Oct 1, 2017, 00:00

  • A Comparative Analysis Of The Health Care Utilization And Costs Of Patients Diagnosed With And Without Liver Cancer In The US Medicare Population

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Treatment with Ultibro Breezhaler® Versus Seretide Diskus® 50/500 Μg for Moderate to Very Severe COPD Patients

    Oct 1, 2017, 00:00

  • Evaluating The Importance Of Realistically Simulating Risk Factor Progression Over Time- A Health Economic Modeling Analysis In Type 1 Diabetes

    Oct 1, 2017, 00:00

  • Disease-Modifying Therapy Is Associated With Lower Medical Costs In Patients With Multiple Sclerosis With or Without Corticosteroid Treatment- A Us Retrospective Claims-Based Study

    Oct 1, 2017, 00:00

  • Insertable Cardiac Monitor Versus Standard of Care For Detection Of Atrial Fibrillation In Patients Following Cryptogenic Stroke- A Dutch Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • IQWIG´S GENERAL METHODS 5.0 - WHAT´S NEW?

    Oct 1, 2017, 00:00

  • Switching of Biological Drugs in Rheumatoid Arthritis- A Cohort of Users from the Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Quality-Adjusted Life Years (QALYS) for Inotuzumab Ozogamicin Versus Investigators Choice (IC) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia (R/R B-ALL)

    Oct 1, 2017, 00:00

  • The Novel Generation And Validation of Survival Curves In Oncology Utilizing Electronic Medical Records Linked To Point of Service Claims Data

    Oct 1, 2017, 00:00

  • Second-Line Therapy In Patients with Locally Advanced or Metastatic Urothelial Cancer- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Validity and Interpretation of A Skin Pain Numeric Rating Scale Among Adults and Adolescents With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Brazilian Public Healthcare System Actions to Care For Children With Microcephaly

    Oct 1, 2017, 00:00

  • Estudo De Custos Da Leishmaniose Visceral No Brasil

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis Of Raasi Enabling-Patiromer In Patients With Hyperkalemia

    Oct 1, 2017, 00:00

  • Access To Medicines For Rare Diseases In Australia- The Current Climate For Reimbursement

    Oct 1, 2017, 00:00

  • Evaluating The Cost-Utility Of Immunosuppressive Regimens In Liver Transplant Recipients In Canada

    Oct 1, 2017, 00:00

  • Pricing Regulation In Greece - Analyzing The Price Bulletin Of December 2016

    Oct 1, 2017, 00:00

  • From Evaluation To Optimization- Using A Meta-Model To Maximize The Benefits Of Colorectal Screening Accounting For Capacity Constraints

    Oct 1, 2017, 00:00

  • Treatment Cost Comparison of Pirfenidone Versus Nintedanib on The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Treatment Patterns for Adult Patients with Newly Diagnosed Focal Epilepsy in Germany

    Oct 1, 2017, 00:00

  • What Can Be Done for Access and Reimbursement Processes To Reward Innovation In Digital “Beyond The Pill” Solutions?

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total HIP Replacement- Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 120,000 Patie ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Reperfusion Strategies For St-Elevation Myocardial Infarction. Real-World Data From The Stent For Life Initiative In Italy

    Oct 1, 2017, 00:00

  • Preliminary Results of Restarting Oral Anticoagulant Treatment In Patients with Non-Valvular Atrial Fibrillation Following Intracranial Hemorrhage- A Population-Based Cohort Study

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Oxycodone In Patients Who Do Not Respond To Morphine From The Brazilian Public Health System Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Fidaxomicin Versus Vancomycin And Metronidazole In Patients With Clostridium Difficile Infection In Spain

    Oct 1, 2017, 00:00

  • Costo Medico Directo Atribuible Al Tratamiento De Pacientes Con Neoplasia Intraepitelial Cervical (CIN) 2 Morfológico E Impacto Económico Del Diagnóstico Diferencial Con Biomarcador P16 En Una Institución Privada De La Ciudad De Buenos Aire ...

    Oct 1, 2017, 00:00

  • Clinical Outcome Assessments For Patients With Hemophilia

    Oct 1, 2017, 00:00

  • Avoiding A Market For Lemons With Pharmaceuticals- How Risk-Sharing Mechanisms Can Improve Allocation

    Oct 1, 2017, 00:00

  • Burden Of Diabetes Mellitus In Patients With Acromegaly Treated With Second-Line Pharmacotherapy In Spain

    Oct 1, 2017, 00:00

  • The Clinical and Cost Effectiveness of Dasatinib Versus Nilotinib for The First and Second Line Treatment of People with Chronic Myeloid Leukaemia

    Oct 1, 2017, 00:00

  • Examining Global Occurrence Of Complications Related To Peripheral Iv Catheters Using A Focused Literature Review

    Oct 1, 2017, 00:00

  • Burden of High Disease Activity in Systemic Lupus Erythematosus (SLE)- Results of A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Diferencias Geográficas En La Salud Auto-Percibida Comunal De Chile

    Oct 1, 2017, 00:00

  • Guidance for Developing A Study Protocol of A Causal Comparative Effectiveness Analysis in “Big Data”- The Case of When To Start Statin Treatment

    Oct 1, 2017, 00:00

  • Secukinumab As A More Efficient Alternative For The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis Versus Adalimumab And Golimumab From A Colombian Perspective

    Oct 1, 2017, 00:00

  • Embedding Randomized Controlled Trials into Medical Practice

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Dolutegravir In HIV-1 Treatment-Naive Patients In Russia

    Oct 1, 2017, 00:00

  • Comparative Evaluation of the Efficacy of Herbal and Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Dysmenorrhea in Women With Female Reproductive Tract Congenital Anomalies

    Oct 1, 2017, 00:00

  • Willingness-To-Pay For Life-Saving Treatments In Thailand- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Considerations for The Selection of Written Chinese Variants In The Process of Translating and Linguistically Validating Clinical Outcome Assessments (COAS)

    Oct 1, 2017, 00:00

  • The Future of Precision Medicine- What Does it Mean for Nice?

    Oct 1, 2017, 00:00

  • Newest Target Therapy And Immunotherapy for the Treatment of Advanced Melanoma- Patterns of Adoption By the Private Health Care Sector in Brazil

    Oct 1, 2017, 00:00

  • Impacto Económico Directo Derivado De La Atención De Pacientes Traumatizados En UN Hospital De México

    Oct 1, 2017, 00:00

  • Which Information Sources Should Be Used To Identify Studies for Systematic Reviews of Economic Evaluations In Healthcare?

    Oct 1, 2017, 00:00

  • Cost of Treatment for Chronic Hepatitis C Infection at a National Tertiary-Care Referral Centre in an Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Mexico

    Oct 1, 2017, 00:00

  • Review Of Models Submitted To Nice Medical Technologies Evaluation Programme To Inform A Cost Consequence Template For Use In Medical Technologies Guidance Submissions

    Oct 1, 2017, 00:00

  • Determinantes Do Atraso Escolar E DA Obesidade NOS Adolescentes Brasileiros (2012 E 2015)

    Oct 1, 2017, 00:00

  • Explaining Waiting Times for Scheduled Surgery Using A High-Dimensional Fixed Effects Model

    Oct 1, 2017, 00:00

  • Access to New Treatments For Chronic Hepatitis C in Four Latin American Countries

    Oct 1, 2017, 00:00

  • Cost Savings of Perioperative Anemia Treatment with Ferric Carboxymaltose In Colorectal Cancer Surgery Patients

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Gasto Y Cobertura De Inmunización En Niños Menores De Un Año De Edad En Ecuador

    Oct 1, 2017, 00:00

  • Using Electronic Health Records As A Real World Comparator- A Case Study In A Single Arm Oncology Trial

    Oct 1, 2017, 00:00

  • Type of Ancestral Native Plants Used as Intestinal Antiparasitic in Indigenous Communities- The Evanes Project

    Oct 1, 2017, 00:00

  • Diabetes Mellitus Self-Management Interventions in Latino Adults in the United States - The Role of Pharmacists

    Oct 1, 2017, 00:00

  • Detección Temprana Del Cáncer De Pulmón

    Oct 1, 2017, 00:00

  • Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome

    Oct 1, 2017, 00:00

  • Maintaining The Belt And Road – The Impact of 'Brexit' on UK Market Access

    Oct 1, 2017, 00:00

  • The Impact of Managed Entry Agreements on Drug Time to Market in Italy

    Oct 1, 2017, 00:00

  • Remote Therapy Management Of Patients On Automated Peritoneal Dialysis Demonstrates Cost Savings In Germany And Italy

    Oct 1, 2017, 00:00

  • Cost of Acute Myocardial Infarction in Colombia (2014)

    Oct 1, 2017, 00:00

  • A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • An Introductive Analysis of the Timeframe from European Drugs Approval to the Sicilian Hospital Formulary Inclusion

    Oct 1, 2017, 00:00

  • Incorporating Dependence Between Model Parameters In Uncertainty Analyses

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation of a Care Bundle Intervention for Preventing Falls Among Italian Aged Inpatients in a Stepped-Wedge Cluster Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Systematic Review Of Economic Evaluation Studies For Dengue Vaccine- How Valid Are The Results?

    Oct 1, 2017, 00:00

  • Knowledge And Attitudes About Ebola Virus Among Community Residents In The US- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Value of Needleless Safety Devices For IV Voriconazole In Prevention of Needlestick Injury (NSI)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Incobotulinumtoxin-A In The Longer-Term Management of Post-Stroke Spasticity of The Upper Limb

    Oct 1, 2017, 00:00

  • Reimbursed Drugs with Alternative Payment Model in Turkey

    Oct 1, 2017, 00:00

  • Effectiveness Of Osteoporosis Drugs In Preventing Secondary Hip Fractures In Women On Dialysis

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures on Health Utilities in PPMS

    Oct 1, 2017, 00:00

  • Sensor Augmented Pum vs Multiple Daily Injections in Very Uncontrolled Diabetes Patients- Cost Model for Hypoglycemic Events, Imss Perspective

    Oct 1, 2017, 00:00

  • Trends In Emerging Non-Hta Drug Value Assessment Frameworks

    Oct 1, 2017, 00:00

  • Effectiveness of The Peripherally Inserted Central Venous Catheter in Adult and Pediatric Patients

    Oct 1, 2017, 00:00

  • Primary Treatment Patterns Among Glaucoma Patients In Korea From 2002 To 2013 Using The National Health Insurance System Claims Data

    Oct 1, 2017, 00:00

  • Stakeholder Perspectives On The Integration Of Patient Preferences In The Medical Product Life Cycle- A Multimethod Approach

    Oct 1, 2017, 00:00

  • The Situation and Importance of Peritoneal Dialysis In Renal Failure- Economic Analysis

    Oct 1, 2017, 00:00

  • Efficacy And Safety Outcomes of Recanalization Procedures In Patients with Acute Symptomatic Pulmonary Embolism- Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Assessing The Implications Of The Nice Budget Impact Test- How Many Oncology Regimens Will Be Affected And What Will Be The Impact On Patient Outcomes?

    Oct 1, 2017, 00:00

  • Secukinumab Provides Higher Symptomatic Improvement Versus Adalimumab in Psoriatic Arthritis- Comparative Effectiveness Up to 48 Weeks Assessed by two Matching-Adjusted indirect Comparisons

    Oct 1, 2017, 00:00

  • Examination Of Adherency Of High-Risk Pregnant Women With Gestational Diabetes Mellitus Care Especially With Respect To Diet And Physical Activity

    Oct 1, 2017, 00:00

  • Real-World Resource Use And Costs Of Treating Controlled And Uncontrolled Carcinoid Syndrome- A Retrospective Swedish Study

    Oct 1, 2017, 00:00

  • Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

    Oct 1, 2017, 00:00

  • Impact of a Community Pharmacy-Based Information Program on Type 2 Diabetic Patients’ Adheren Iphodia, a Cluster Randomized Study VS Usual Practice - 12 Month Final Results

    Oct 1, 2017, 00:00

  • Cataract Prevalence Estimation and Financial Requirements for Surgery Unmet Needs in Mexico- A Secondary Sources Analysis

    Oct 1, 2017, 00:00

  • Real-World Patient Characteristics And Patterns Of Care Among Metastatic Urothelial, Head And Neck, Non-Small Cell Lung Cancer Patients Using A German Sickness Fund Claims Database

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Brazil

    Oct 1, 2017, 00:00

  • Costo-Efectividad De La Cirugía Bariátrica En Colombia

    Oct 1, 2017, 00:00

  • Prescription Writing Errors Detection by Pharmacist in A Pediatric Ward

    Oct 1, 2017, 00:00

  • Analysis of The Individual Economic Burden (BORNE-COST BY THE PATIENTS) In Adult Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Effect of Pharmacist Care on Medication Adherence and Cardiovascular Outcomes Among Patients Post-Acute Coronary Syndrome- A Systematic Review

    Oct 1, 2017, 00:00

  • Great Saphenous Vein Radiofrequency Ablation Versus Standard Stripping in The Management of Primary Varicose Veins- Economic Evaluation Into the Mexican Context

    Oct 1, 2017, 00:00

  • Survival Effect, Demand Effect And Policy Effect As Drivers For Pricing Of Innovatives Anticancer Drugs

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Exemestane Versus Capecitabine Monotherapy for Patients with Hormone Receptor–Positive and Her2-Negative, Metastatic Breast Cancer from National Cancer Institute Prespective in Egypt

    Oct 1, 2017, 00:00

  • Primary Data Collection Versus use of Retrospective Claims Data- Methodology Lessons Learned from A Linked Database Study in Chronic Obstructive Pulmonary Disease (COPD)

    Oct 1, 2017, 00:00

  • Health State Utilities Associated with Treatment Options for Acute Myeloid Leukemia (AML)

    Oct 1, 2017, 00:00

  • Budgetary Impact Analysis of the Nutritional Home Care Service

    Oct 1, 2017, 00:00

  • A Trend Towards Increased Use Of Patient Access Schemes (PAS) To Gain UK Reimbursement

    Oct 1, 2017, 00:00

  • Treatment Patterns Of Second-Line (2L) Metastatic Urothelial Cancer (MUC) In Spain

    Oct 1, 2017, 00:00

  • Health Care Use Among Incident Cases of Heart Failure- A Population-Based Cohort Study from 1997 To 2010

    Oct 1, 2017, 00:00

  • A Multicenter, Observational Study To Evaluate Comorbidities In Patients Above 50 Years Of Age – Aging Positive- Characterization Of The Healthcare Resource Use

    Oct 1, 2017, 00:00

  • Early Economic Evaluation of The New Atypical Antipsychotic

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective- Evidence From The Switch 12 Trials

    Oct 1, 2017, 00:00

  • Attitudes Towards Generic Substitution In Greece

    Oct 1, 2017, 00:00

  • Metodology To Assess Pricing And Reimburesment (PR) Potential In Central And European (CEE) Countries

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Cerebral Oximetry Monitoring In Carotid Endarterectomy- The Emocar Randomized Controlled Trial (May 2011 - April 2016)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Midostaurin (MIDO) with Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)

    Oct 1, 2017, 00:00

  • Analysis of The Budget Impact of Secukinumab use Versus Anti-Tnf Agents in Ankylosing Spondylitis Patients

    Oct 1, 2017, 00:00

  • Identifying Patients With Lupus Nephritis in the United Kingdom (Uk) Clinical Practice Research Datalink (Cprd)

    Oct 1, 2017, 00:00

  • The Traditional Ethnobotanical Knowledge Applied in Parasitology in the Andean Cordillera of Ecuador

    Oct 1, 2017, 00:00

  • Assessing the Burden of Chronic Heart Failure on Caregivers of Patients in Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Quadrivalent Influenza Vaccine For National Immunization Program In South Korea

    Oct 1, 2017, 00:00

  • Treatment Persistence In Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Rosuvastatin Compared To Atorvastatin In Primary Prevention Of Myocardial Infarction Among HIV-Positive Patients On Haart In Uganda

    Oct 1, 2017, 00:00

  • Patient Experience Assessments in Advanced Gastric, Esophageal, and Gastroesophageal Junction Cancer Studies

    Oct 1, 2017, 00:00

  • Patients Oriented Access Scheme- Learning From The Success Of The Israeli Innovative Solution For The Escalating Drugs Prices

    Oct 1, 2017, 00:00

  • Burn Care Outside Burn Centers In Germany; Results From An Analysis of Hospital Quality Reports

    Oct 1, 2017, 00:00

  • IMPACT OF WEIGHT LOSS (WL) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG LATIN AMERICAN (LA) SUBJECTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN PHASE 3 STUDIES OF CANAGLIFLOZIN (CANA)

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Axitinibe Na Segunda Linha De Tratamento Do Carcinoma De Células Renais Metastático Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy- A Modeling Approach By The Brazilian Public Health Care System Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of 10% Intravenous Immunoglobulin Compared With Plasma Exchange In Treatment Of Children With Guillain–Barré Syndrome In Russia

    Oct 1, 2017, 00:00

  • Implementability Evaluation Of Antibiotics For Abdominal Trauma Guideline Using The Guideline Implementability Appraisal (GLIA) Tool

    Oct 1, 2017, 00:00

  • Initiatives That Impact Pricing And Reimbursement of Orphan (AND ULTRA ORPHAN) Drugs- Review of European Trends

    Oct 1, 2017, 00:00

  • Systematic Review of The Cost-Effectiveness of Medicines For The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • No Evidence For An Association Between Renal Function And Bleeding Events In Patients On Coumarin Therapy- A Population-Based Study

    Oct 1, 2017, 00:00

  • A Longitudinal Investigation Of The Relationships Between Patient-Reported Symptoms And Survival Among Patients with HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib In The Phase 2 Monarch 1 Trial

    Oct 1, 2017, 00:00

  • Evaluating Access To Treatment- A Comparison of The Expected Number of Patients with Metastatic Colorectal Cancer (Mcrc) To Those Effectively Treated in The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Price Comparison Of New Drugs In Japan, Eu And Us

    Oct 1, 2017, 00:00

  • Subcutaneous Drugs In Oncology- Make A Difference In The Treatment? Systematic Review From Different Analytical Perspectives

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Breech Version By Moxibustion Associated With Acupuncture For Women At 33 Weeks Gestation- A Modeling Approach By The Brazilian Public Health Care System Perspective

    Oct 1, 2017, 00:00

  • Adequacy of Glycemic Control in Greek Patients with Type 2 Diabetes Mellitus Treated with Metformin Monotherapy at the Maximum Tolerated Dose- The Reload Study

    Oct 1, 2017, 00:00

  • Overview Of Innovative Medicine Sector In Turkey

    Oct 1, 2017, 00:00

  • Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

    Oct 1, 2017, 00:00

  • Societal Costs of Er+/Her2- Advanced or Metastatic Breast Cancer in Post-Menopausal Women in The United Kingdom

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of Multivalent Vaccination Against Infectious Causes of Reproductive Disorders in Brazilian Cow-Calf Beef Herds Using Artificial Insemination

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Alemtuzumab In Comparison With Natalizumab, Intramuscular Interferon Beta-1a, Subcutaneous Interferon Beta-1b, And Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis In Iran

    Oct 1, 2017, 00:00

  • A Literature Review of Health Economic Assessments, Health Care Resource Utilization (HCRU), and Health Related Quality-of-Life (HRQOL) in Patients with Gastric Cancer (GC)

    Oct 1, 2017, 00:00

  • Do we Know Enough Yet? A Cumulative Cost-Effectiveness Analysis of Mechanical Thrombectomy

    Oct 1, 2017, 00:00

  • Health-Related Quality Of Life And Pharmacotherapy Costs Study For Patients With Rare Endocrine Diseases In Bulgaria – A Pilot Study

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Ixabepilone Monotherapy in Patients with Advanced or Metastatic Breast Cancer Resistant To Anthracyclines, Taxanes and Capecitabine

    Oct 1, 2017, 00:00

  • Exploring Concurrent Validity of The CLN2 Clinical Rating Scale- Comparison To Pedsql Using Mixed Effects Modelling And Data From A Phase 1/2 Single-Arm Trial

    Oct 1, 2017, 00:00

  • Secukinumab vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from a Brazilian Perspective

    Oct 1, 2017, 00:00

  • Treatment Patterns and Satisfaction For Rheumatoid Arthritis Patients In Latin America Undergoing Advanced Therapy

    Oct 1, 2017, 00:00

  • Easipro3 – Enhancing Satisfaction With Prostate Cancer Treatment Decision With The Mobile Health Program Prostana- A Multicenter Randomized Controlled Trial

    Oct 1, 2017, 00:00

  • Advanced Therapy Medicinal Products – Transformational Patient Benefits But Destined for Commercial Failure?

    Oct 1, 2017, 00:00

  • Economic Burden of Gastric Cancer in Turkey

    Oct 1, 2017, 00:00

  • Cost Effective Analysis Of Pharmaceutical Care In Management Of Patients With Stage Iii Hypertension- An Indian Pharmacists Experience

    Oct 1, 2017, 00:00

  • Secukinumab Vs Adalimumab for the Treatment of Ankylosing Spondilytis- A Cost Per Responder Analysis at 52 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • A Saúde Do Trabalhador Em Questão- Análise Do Absenteísmo E O Perfil Dos Atestados Médicos Em Um Hospital De Grande Porte No Ceará

    Oct 1, 2017, 00:00

  • Gene-Therapy, The Way Forward In Europe – The Payer Perspective

    Oct 1, 2017, 00:00

  • Assessment Of Hypertension Patients’ Adherence In Bulgaria – Pilot Study

    Oct 1, 2017, 00:00

  • Economic Analysis of The Use of Non-Invasive Prenatal Test (NIPT) For Prenatal Screening of Trisomy 21, 18, 13 In Pregnant Women

    Oct 1, 2017, 00:00

  • ADC, NOT AS EASY AS 123 - The Unprecedented Example Of Trastuzumab-Emtansine In The Nice Appraisal Process

    Oct 1, 2017, 00:00

  • Analytical Hierarchical Process for Evaluation of First Line Treatment of Metastatic HER2 Overexpressed Breast Cancer from Brazilian Health System Perspective

    Oct 1, 2017, 00:00

  • Evaluation of The Clinical Effectiveness of Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib And Best Supportive Care (BSC) In Previously Treated Advanced or Metastatic Renal Cell Carcinoma (AMRCC)- A Systematic Review And Mixed-Tre ...

    Oct 1, 2017, 00:00

  • Continuous Subcutaneous Infusion Versus Multiple Dose Injection of Insulin For Newly-Diagnosed T1D Paediatric Patients- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Universal Neonatal Hearing Screening With Otoacoustic Emissions And/Or Automated Auditory Brainstem Response, For The Detection Of Bilateral Congenital Hearing Loss And Early Treatment, In Newborns Without Risk Factors ...

    Oct 1, 2017, 00:00

  • Physiotherapeautic Methods Aimed To Improve The Cardiorespiratory State Before And After Operation In Patients With Lung Cancer

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from A Brazilian Perspective

    Oct 1, 2017, 00:00

  • Influenza Vaccination Among Pregnant Women- Exploratory Analysis From The 2012-2015 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Strategies for Cervical Cancer Prevention and Control in Indonesia

    Oct 1, 2017, 00:00

  • Phase I/II Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • Key Drivers In Health Technology Assessment By Analysing The Level Of Improvement In Actual Benefit In Solid Tumor Oncology Drugs

    Oct 1, 2017, 00:00

  • Analysis of Clinical And Economic Effectiveness of Statins For Secondary Prevention of Cardiovascular Disease In Kazakhstan

    Oct 1, 2017, 00:00

  • The Impact of Missed Treatment Opportunities on Outcomes In Hospitalised Heart Failure Patients- Modelling Analysis Based on The National Heart Failure Audit

    Oct 1, 2017, 00:00

  • Relation of QLQ-C30 and QLQ-CR29 Health Related Quality of Life Scales and Biochemical Indicators of Nutritional Status

    Oct 1, 2017, 00:00

  • Pharmaceutical Care Workload And Workforce Requirement At Ministry Of Health Primary Care Centers During Ten Years Mass Gathering Hajj (2006-2015) In Makah Regions, Saudi Arabia

    Oct 1, 2017, 00:00

  • Productivity Costs Related to Bortezomib And Carfilzomib Administration For Multiple Myeloma In Finland

    Oct 1, 2017, 00:00

  • Pricing Pantoprazole In Gree A Tale Of Distortion

    Oct 1, 2017, 00:00

  • Microbiological, Chemical Analysis and Comparison of Public Bath Waters in Baranya County Between 2010-2016

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Bezlotoxumab + Standard Of Care (SOC) Versus Placebo + Soc For The Prevention Of Recurrent Clostridium Difficile Infection In The United Kingdom

    Oct 1, 2017, 00:00

  • How To Address French Health Authority (HAS/CEESP) Specific Requirements In Modelling Relapsing-Remitting Multiple Sclerosis In Health-Economic Evaluation? Modelling Treatment Sequences

    Oct 1, 2017, 00:00

  • Surgical Treatment Outcome of Lumbar Disc Herniation (LDH) In Different Ages

    Oct 1, 2017, 00:00

  • Análisis Del Costo De La Atención Del Parto En Medellín

    Oct 1, 2017, 00:00

  • Pharmatool- An Economic and Epidemiological Calculation Tool To Aid Planning For Reducing Cardiovascular Morbidity In Brazil

    Oct 1, 2017, 00:00

  • Preferences of Parents To Avoid Oral Health Outcomes In Children- Results of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Availability of Health Economic Model Inputs In Japan- A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Patient Care Pathway for Post-Stroke Spasticity and Bont Management in French Hospitals Through the Prism of PMSI Data

    Oct 1, 2017, 00:00

  • The Economic Impact of Switching To Herceptin (TRASTUZUMAB) Biosimilar for The Treatment of Metastatic Breast Cancer From A UK Payer Perspective

    Oct 1, 2017, 00:00

  • Prospective Assessment of The Accuracy, Reliability and Cost-Effectiveness of Staging Non-Small Cell Lung Cancer (NSCLC) Only with The Combination of Pet/Ct and Brain MRI

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Coblation Technology VS. Mechanical Debridement With A Shaver In The Treatment Of Knee Cartilage Lesions- A Spanish Payer Perspective

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • The Economic Impact of Rheumatoid Arthritis on Patients’ Households. An Estimation of The Disease Related Catastrophic Health Expenditure, In Greece

    Oct 1, 2017, 00:00

  • Reliability, Validity and Responsiveness of A New Measure of Neck Disability (ND10)

    Oct 1, 2017, 00:00

  • A Multi-Centre Retrospective Study To Describe The Impact on Healthcare Resource Use And Real World Effectiveness of Golimumab In Ankylosing Spondylitis (AS) In UK Clinical Practice

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Three European Countries Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Symptom Deterioration in Patients with Metastatic Renal Cell Carcinoma Treated with Cabozantinib or Everolimus

    Oct 1, 2017, 00:00

  • Opioid Utilization And Cost Among Elderly And Non-Elderly Medicare Beneficiaries In The United States- A State-Level Comparison

    Oct 1, 2017, 00:00

  • Biosimilar Uptake In The Uk- An Evolving Story?

    Oct 1, 2017, 00:00

  • A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods

    Oct 1, 2017, 00:00

  • Health-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules

    Oct 1, 2017, 00:00

  • Analysis Of Hospital Episode Statistics To Identify Hopsital Resource Use Due To Skin Cancer In Ireland

    Oct 1, 2017, 00:00

  • Cognitive Debriefing Of The Dmd-Specific Measures Of Physical Functioning – Caregiver Questionnaire

    Oct 1, 2017, 00:00

  • Examination of The Effectiveness of Core Training Between Junior Women Basketball Players To Prevent Sports Injuries

    Oct 1, 2017, 00:00

  • Reliability And Validity Of The Mobility Section Of The Prosthesis Evaluation Questionnaire And Its Modified Version. Do They Measure The Same Construct?

    Oct 1, 2017, 00:00

  • Patients’ Priorities for Oral Anticoagulation Therapy in Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Intravenous Iron Treatments For Iron Deficiency Anemia In Inflammatory Bowel Disease- A Budget Impact Analysis Of Iron Isomaltoside 1000 In The UK

    Oct 1, 2017, 00:00

  • HTA Analysis of Intraocular Lenses After Cataract Surgery- Hydrophobic Vs. Hydrophilic Lenses - Health Technology Assessment In Slovak Healthcare Environment

    Oct 1, 2017, 00:00

  • Clinical Characteristics Of Patients With Chronic Hepatitis C Infection At Initial Presentation To Tertiary Care In An Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Introduction For Heart Failure Treatment From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • Uncertainty In Selecting Survival Models For Cost Effectiveness Analyses

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Assessment Of Herpes Zoster Vaccination In Germany

    Oct 1, 2017, 00:00

  • The Potential Value Of Real-World Evidence Along With Trial Efficacy To Estimate Effectiveness Of Novel Treatments In Real-World Setting; An Application With Overall Survival In Two Oncology Indications

    Oct 1, 2017, 00:00

  • Quality of Life And Utility Decrement Associated With Clostridium Difficile Infection In French Acute Care Facilities

    Oct 1, 2017, 00:00

  • Can Bayesian Methodology Predict Long-Term Effectiveness Rather Than Efficacy? An Application with Overall Survival in Two Oncology Indications

    Oct 1, 2017, 00:00

  • Testosterone Replacement therapy As An Anti-Ageing Treatment for Men- A Literature Review and Economic Evaluation

    Oct 1, 2017, 00:00

  • Off-Label Drug Use In Hospitalized Children- A Prospective Observational Study At Gondar University Referral Hospital, Northwestern Ethiopia

    Oct 1, 2017, 00:00

  • Defining Criteria Weights By AHP In Health Technology Assessment

    Oct 1, 2017, 00:00

  • In What Sequence Do Companies Submit Health Technology Appraisal (HTA) Dossiers In The UK And Ireland, And In What Sequence Are They Published?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients Under the Perspective of the Brazilian Private Healthcare System

    Oct 1, 2017, 00:00

  • The Cost Of Treating Diabetic Ketoacidosis In The UK- A National Survey Of Hospital Resource Use

    Oct 1, 2017, 00:00

  • Epidemiology of Multiple Sclerosis- Literature Review for Prevalence and Trend Over Time in 5 European Countries and Canada

    Oct 1, 2017, 00:00

  • Clinical and Patient Reported Outcomes In Psoriatic Arthritis- A Narrative Review of The Literature

    Oct 1, 2017, 00:00

  • Analysis of the G-BA Decision-Making Criteria on the Benefit Assessment of Diabetes Treatments- Is Cost an Influencing Criterion?

    Oct 1, 2017, 00:00

  • Impact Of Genomic Testing Billing Practices On Utilization In Academic Hybrid Oncology Practice

    Oct 1, 2017, 00:00

  • Maximizing The Value of Wearable By The Remote Collection And Analysis Of Raw 100hz Data

    Oct 1, 2017, 00:00

  • Treatment Cost of Hepatocellular Carcinoma from The Health Insurance’s Perspective in Viet Nam

    Oct 1, 2017, 00:00

  • The Role of Patient-Reported Outcomes and Patient Engagement In Health Technology Assessments and Reimbursement Decision Making In 10 Countries

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Easypod™ Device Versus Other Somatotropin Delivery Techniques In Egypt In Treatment of Growth Hormone Deficiency

    Oct 1, 2017, 00:00

  • Epidemiology of Physician-Diagnosed Neuropathic Pain in Brazil

    Oct 1, 2017, 00:00

  • Measurement Of Multimorbidity To Predict All-Cause Mortality In A Nationwide Population, Using The French National Health Insurance Database (SNIIRAM)

    Oct 1, 2017, 00:00

  • Economic Evaluation of Multi-Drug Resistant Tuberculosis In Ghana- Patient Level Direct Cost Analysis 2013 - 2016

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Invasive Fungal Infections Therapies In Febrile Neutropenic Patients With Hematological Malignancies In The Turkish Context

    Oct 1, 2017, 00:00

  • Creating Order In Chaos - The Impact Of Brexit On The Regulatory Environment In Europe And The United Kingdom

    Oct 1, 2017, 00:00

  • Angiotensin II Receptor Blockers And Intestinal Malabsorption- An Observational Cohort Study In Germany And Italy

    Oct 1, 2017, 00:00

  • Uso De Medicamentos Inapropriados Em Idosos Institucionalizados No Município De São Paulo, Brasil

    Oct 1, 2017, 00:00

  • A Cost Consequences Analysis of The Human Body Posturizer In Italy

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis In Health Economic Models; How Many Simulations Should We Run?

    Oct 1, 2017, 00:00

  • Parametric Modelling of Migraine Day Frequency In Migraine Prevention- A Case Study Of Erenumab Clinical Trial Data

    Oct 1, 2017, 00:00

  • Nice’s New Budget Impact Threshold – What Proportion Of Drugs Is This Likely To Affect?

    Oct 1, 2017, 00:00

  • Patient Counts Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • Budget Impact of Atezolizumab for The Treatment of 2nd Line Non-Small Cell Lung Cancer (NSCLC) After Failure with Platinum Containing Chemotherapy in Greece

    Oct 1, 2017, 00:00

  • The Examination Of Location And Frequency Of Pain In Weight Training

    Oct 1, 2017, 00:00

  • Comparison of Budesonide Inhalers For Treatment of Asthma In Adults And Adolescents In Russian Federation- Cost – Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Prasugrel For Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention In Spain

    Oct 1, 2017, 00:00

  • Prevalence And Perception Of Antibiotics Use In Balochistan

    Oct 1, 2017, 00:00

  • The Need For Developing A Decision Aid Tool About Feeding Options

    Oct 1, 2017, 00:00

  • New Modelling Approaches In Ophthalmology- Partitioned Vision Distrbution Model In Symptomatic Vitreomacular Adhesion (VMA)/Vitreomacular Traction (VMT) With Or Without Full-Thickness Macular Hole (FTMH)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Interferon-Free Treatment Strategies For Hepatitis C After Generic Entry Of Direct-Acting Antivirals In The Kazakhstan

    Oct 1, 2017, 00:00

  • Comparing the Efficacy, Safety, and Efficiency Outcomes Between Lensx Femtosecond Laser-Assisted Cataract Surgery and Phacoemulsification Cataract Surgery- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Retrospective Analysis of the Use of Incremental Cost-Effectiveness Ratio (Icer) in Technology Incorporation in the Brazilian Public Health System (Sus), 2012-2016, Perspectives and Challenges for the Brazilian Context

    Oct 1, 2017, 00:00

  • Burden Of Respiratory Syncytial Virus (RSV) Disease In Adults- Final Analysis From A Retrospective Chart Review

    Oct 1, 2017, 00:00

  • Evaluation of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (RTCGM) Versus Self Monitoring Of Blood Glucose (SMBG) Alone In Type 1 Diabetes From The Swedish Societal Perspective

    Oct 1, 2017, 00:00

  • Statistical Methods for Critical Care Outcomes

    Oct 1, 2017, 00:00

  • A Systematic Review Of Calibration In Population Models

    Oct 1, 2017, 00:00

  • Neutrophil-To-Lymphocyte Ratio (NLR) As A Predictor For Recurrencein Patients With Stage Iii Melanoma

    Oct 1, 2017, 00:00

  • Evaluation of Appropriateness of Antibiotics in the Intensive Care Unit of a Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • GROWTH FACTORS FOR THE MANAGEMENT OF DIABETIC FOOT ULCERS- MIXED TREATMENT COMPARISONS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2017, 00:00

  • Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • Forecasting Pharmaceutical Expenditure In Europe- Adjusting For The Impact Of Rebates And Discounts

    Oct 1, 2017, 00:00

  • Prevalence of Overweight and Obesity Among Health Personnel in an Urban Ghana- A Descriptive Cross-Sectional Study, 2017

    Oct 1, 2017, 00:00

  • A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Consistency Assessment of International Drug Price Comparisons

    Oct 1, 2017, 00:00

  • Quality of life improvement in a heart failure clinical program vs. Conventional management in a specialized clinic in colombia

    Oct 1, 2017, 00:00

  • The Comparison Among Different Countries’ EQ-5D-5L Value Sets Applied In Chinese General Population

    Oct 1, 2017, 00:00

  • The Value Of Real-World Evidence To Support Value-Based Decision-Making- Examples For Vedolizumab In Inflammatory Bowel Disease

    Oct 1, 2017, 00:00

  • Review Of Reimbursement Decision Drivers For Rare Cancer Therapies Across EU5 Markets

    Oct 1, 2017, 00:00

  • Patient Preferences for Interferon-Beta in Iran- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Comparative Analysis of Lists of Antifungal Preparations for Onychomycosis Treatment In British and Ukrainian National Formularies

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis Of Increasing Peritoneal Dialysis (PD) In Adults Experiencing Unplanned Start Dialisys (Urgent Start) In Brazil

    Oct 1, 2017, 00:00

  • The Associated Factors of Neuropathic Pain Among Chronic Low Back Pain Patients in South Korea- Findings from the NLBP OR

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization And Cost Of Patients With Acute Coronary Syndromes In Tianjin, China

    Oct 1, 2017, 00:00

  • The Value Of Beds With Continuous Lateral Rotation Therapy To Prevent Ventilator-Associated Pneumonia And Pressure Injuries- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Determinantes Dos Custos Dos Processos Judiciais De Medicamentos Em Um Município Da Região Centro-Oeste Do Brasil

    Oct 1, 2017, 00:00

  • Barriers To Access And Pricing Negotiations Criterial Selection For Novel Treatments For Hepatitis C In The Greek Healthcare Context

    Oct 1, 2017, 00:00

  • Medicine Prices Disparity Among Retail Pharmacies In Selangor, Malaysia

    Oct 1, 2017, 00:00

  • Electronic Patient-Reported Outcomes- Are There Gaps Between Guidance And Issues Encountered In Practice?

    Oct 1, 2017, 00:00

  • Evaluating Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison Techniques- Impact on Health-Related Quality of Life of Focussed Ultrasound Thalamotomy and Other Interventions for the Treatment of Medication-Refractory E ...

    Oct 1, 2017, 00:00

  • Cost and Treatment of Asthma and Copd in the Real Practi A Regional Segmentation

    Oct 1, 2017, 00:00

  • Internet Based Treatment of Depressive Symptoms – A Health Economic Evaluation of Costs and Benefits

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of A Novel Breath-Triggered Aerosol Inhaler Which Has Been Designed To Reduce The Critical Handling Error of Insufficient Inspiratory Effort

    Oct 1, 2017, 00:00

  • Fluoroquinolone-Related Adverse Events Resulting In Health Care Use And Costs- A Systematic Review

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66 (current)
  • 67
  • 68
  • 69
  • 70
  • »